Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00874419 |
|---|---|
| Brief Title: | Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation (ML20981) |
| First Submitted : | April 1, 2009 |
| First Submitted that Met QC Criteria : | April 1, 2009 |
| First Posted : | April 2, 2009 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 23, 2014 |
| Last Update Posted : | September 25, 2014 (Estimate) |